^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Portrait Flex assay

Company:
ANGLE
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
Twitter
ANGLE developed the immunofluorescence (IF) Portrait Flex assay for the detection of epithelial and mesenchymal circulating tumour cells (CTCs) as well as those undergoing the epithelial-mesenchymal transition (EMTing). Additionally, the assay offers the customer the possibility of adding any bespoke protein biomarker, depending on its needs. The assay has high sensitivity and specificity (>90%) for epithelial and mesenchymal CTCs, which are known to be involved in cancer metastasis and drug resistance and was launched in late 2022 as an offering to pharma services customers.
Cancer:
Solid Tumor
Method:
Immunofluorescence